Moolec Science SA (MLECW)
USD 0.05
(-6.24%)
USD 0.05
(-6.24%)
| Breakdown | 2023 | 2022 | 2020 |
|---|---|---|---|
| Revenue | 905.04 Thousand | - | - |
| Cost of Revenue | 1.04 Million | - | - |
| Gross Profit | -143.3 Thousand | - | - |
| Operating Expenses | 52.75 Million | 3.65 Million | 13.8 Thousand |
| Selling, General and Administrative Expenses | 47.67 Million | 2.62 Million | 13.8 Thousand |
| Research and Development Expenses | 1.35 Million | 985.15 Thousand | - |
| Other Expenses | -62.26 Thousand | - | - |
| Cost and Expenses | 53.79 Million | 3.65 Million | 13.8 Thousand |
| Operating Income | -6.65 Million | -3.65 Million | -13.8 Thousand |
| Interest Expense | 160.03 Thousand | 2130.00 | - |
| Income Tax Expense | -234.54 Thousand | 2130.00 | -206.29 Thousand |
| Earnings before Tax | -52.02 Million | -4.52 Million | -13.8 Thousand |
| Net Income | -51.78 Million | -4.52 Million | -13.8 Thousand |
| Earnings Per Share Basic | -1.50 | -0.26 | -0.00 |
| Earnings Per Share Diluted | -1.50 | -0.26 | -0.00 |
| Weighted Average Shares Outstanding | 34.46 Million | 17.37 Million | 17.37 Million |
| Weighted Average Shares Outstanding (Diluted) | 34.46 Million | 17.37 Million | 17.37 Million |
| Gross Margin | -0.16 | - | - |
| EBIT Margin | -57.54 | - | - |
| Profit Margin | -57.22 | - | - |
| EBITDA | -52.07 Million | -3.65 Million | -13.8 Thousand |
| Earnings Before Tax Margin | -7.35 | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.1 Million | 252.11 Thousand | 1.74 Million | 905.04 Thousand | 905.04 Thousand | - |
| Cost of Revenue | 2.01 Million | 261.24 Thousand | 1.51 Million | 1.04 Million | 1.04 Million | - |
| Gross Profit | 91.74 Thousand | -9131.00 | 220.4 Thousand | -143.3 Thousand | -143.3 Thousand | - |
| Operating Expenses | 2.13 Million | 1.97 Million | 2.48 Million | 52.75 Million | 3.94 Million | 444.69 Thousand |
| Selling, General and Administrative Expenses | 1.83 Million | 1.54 Million | 1.94 Million | - | 3.42 Million | 775.34 Thousand |
| Research and Development Expenses | 447.62 Thousand | 423.95 Thousand | 387.73 Thousand | - | 370.63 Thousand | 576.09 Thousand |
| Other Expenses | - | - | - | -62.26 Thousand | -62.26 Thousand | - |
| Cost and Expenses | 4.15 Million | 2.23 Million | 4 Million | 53.79 Million | 4.98 Million | 444.69 Thousand |
| Operating Income | -2.04 Million | -1.98 Million | -2.26 Million | -6.65 Million | -548.38 Thousand | -444.69 Thousand |
| Interest Expense | 358.82 Thousand | 103.39 Thousand | 99.41 Thousand | 160.03 Thousand | - | - |
| Income Tax Expense | 126.95 Thousand | -235.99 Thousand | -215.29 Thousand | -234.54 Thousand | -234.54 Thousand | -26.65 Thousand |
| Earnings before Tax | -1.27 Million | -2.01 Million | -1.8 Million | -52.02 Million | -2.98 Million | -358.57 Thousand |
| Net Income | -1.4 Million | -1.78 Million | -1.59 Million | -51.78 Million | -2.74 Million | -358.57 Thousand |
| Earnings Per Share Basic | -0.04 | -0.05 | -0.04 | - | -0.07 | -0.01 |
| Earnings Per Share Diluted | -0.04 | -0.05 | -0.04 | - | -0.07 | -0.01 |
| Weighted Average Shares Outstanding | 37.76 Million | 37.8 Million | 37.8 Million | 34.46 Million | 37.56 Million | 37.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.76 Million | 37.8 Million | 37.8 Million | 34.46 Million | 37.56 Million | 37.56 Million |
| Gross Margin | 0.04 | -0.04 | 0.13 | -0.16 | -0.16 | - |
| EBIT Margin | -0.30 | -6.87 | -1.00 | - | -3.24 | - |
| Profit Margin | -0.66 | -7.07 | -0.91 | -57.22 | -3.04 | - |
| EBITDA | -627.05 Thousand | -1.73 Million | -1.73 Million | - | -2.93 Million | -444.27 Thousand |
| Earnings Before Tax Margin | -0.97 | -7.87 | -1.30 | -7.35 | -0.61 | - |
HPIL
KELENRG
BCUFF
POL
VVC
AMROF